See also this year's filing and all EDGAR filings for this company.
PDF Report 0001867096_2023_Xeris_Biopharma_Holdings_Inc.pdf
Logs
Graph
Absolute values for 0001867096, Xeris Biopharma Holdings Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 186,818,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 143,466,000 |
| 2 | PropertyPlantAndEquipmentNet | 5,516,000 |
| 3 | remainder_Assets | 8,722,000 |
| 4 | LiabilitiesCurrent | 73,621,000 |
| 5 | LiabilitiesNoncurrent | 9,433,000 |
| 6 | remainder_Liabilities | 216,281,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 137,745,000 |
| 9 | ResearchAndDevelopmentExpense | 20,966,000 |
| 10 | remainder_Expenses | 32,053,000 |
| 11 | remainder_Revenues | 110,248,000 |
| 12 | remainder_NetIncome | -14,144,000 |
| 13 | remainder_ComprehensiveNetIncome | 8,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 344,522,000 |
| 1 | Liabilities | 299,335,000 |
| 2 | Expenses | 190,764,000 |
| 3 | Revenues | 110,248,000 |
| 4 | StockholdersEquity | 45,187,000 |
| 5 | NetIncome | -94,660,000 |
| 6 | ComprehensiveNetIncome | -94,656,000 |
| 7 | BaseVar | 479,510,500 |
| 8 | EconomicCapitalRatio | -0.0526 |
Edgar->Model Mapping
Feature Distribution
Change over Time
